Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
They stimulate the central nervous system (CNS) and are FDA-approved to treat attention-deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder associated with hyperactivity, inattention, and impulsivity
Diagnosis and management of status epilepticus: improving the status quo
Efforts to develop alternative treatment strategies have been undertaken
The weight loss achieved with GLP-1 therapy appears central to hepatic benefits, as weight reduction of 710% consistently improves NAFLD across multiple intervention studies
doi: 10.3389/fphys.2018.00477 173 LuS
US$ 22.67
US$ 22.26
US$ 26.24
